Elon Musk says the first human has received an implant from Neuralink, but other details are scant

FILE - Elon Musk appears at an event with Britain's Prime Minister Rishi Sunak in London, on Nov. 2, 2023. According to Musk, the first human received an implant from his computer-brain interface company Neuralink over the weekend. (AP Photo/Kirsty Wigglesworth, Pool, File)
Subscribe Now Choose a package that suits your preferences.
Start Free Account Get access to 7 premium stories every month for FREE!
Already a Subscriber? Current print subscriber? Activate your complimentary Digital account.

According to Elon Musk, the first human received an implant from his computer-brain interface company Neuralink over the weekend.

In a Monday post on X, the platform formerly known as Twitter, Musk said that the patient received the implant the day prior and was “recovering well.” He added that “initial results show promising neuron spike detection.”

The billionaire, who co-founded Neuralink, did not provide additional details about the patient. When Neuralink announced in September that it would begin recruiting people, the company said it was searching for individuals with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s Disease.

Neuralink is one of many groups working on linking the nervous system to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications. There are more than 40 brain computer interface trials underway, according to clinicaltrials.gov.

Neuralink reposted Musk’s Monday post on X, but did not publish any additional statements acknowledging the human implant. The company did not immediately respond to The Associated Press’ requests for comment Tuesday.

Neuralink previously announced that the U.S. Food and Drug Administration had approved its “investigational device exemption,” which generally allows a sponsor to begin a clinical study “in patients who fit the inclusion criteria,” the FDA said Tuesday. The agency pointed out that it can’t confirm or disclose information about a particular study.

Neuralink’s device is about the size of a large coin and is designed to be implanted in the skull, with ultra-thin wires going directly into the brain. Neuralink said the wires would be surgically placed in a region of the brain that controls movement intention.